Hartland & Co »

Zenas Biopharma shares owned by Hartland & Co

Quarter-by-quarter ownership of Zenas Biopharma (ZBIO) shares owned by Hartland & Co from 13F filings

Historical chart of Hartland & Co investment in Zenas Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Zenas Biopharma held by Hartland & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Zenas Biopharma by Hartland & Co

Quarter filed Position value Share count Share price at filing
2025-09-30 $511 23 22.22
2025-06-30 $223 23 9.70

More positions owned by Hartland & Co

Vanguard Index Fds S&p 500 Etf Shs Put Option (Principal) (VOO)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Rus 1000 Grw Etf (IWF)
Apple (AAPL)
Vanguard Index Fds Mid Cap Etf (VO)
Microsoft Corporation (MSFT)
Vanguard Index Fds Small Cp Etf (VB)
Vanguard Index Fds Value Etf (VTV)
Spdr Index Shs Fds Portfolio Devlpd (SPDW)
Vanguard Scottsdale Fds Mtg-bkd Secs Etf (VMBS)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Dimensional Etf Trust Intl Core Eqt Mk (DFAI)
NVIDIA Corporation (NVDA)
Wisdomtree Tr Us Largecap Divd (DLN)
Spdr S&p 500 Etf Tr Tr Unit (SPY)

View all positions for Hartland & Co

Top funds holding Zenas Biopharma

Sr One Capital Management
FMR
Enavate Sciences GP
NEA Management Company
Novo A/S
Fairmount Funds Management
Federated Investors
NVP Associates
Deerfield Management Company
BlackRock
Vivo Capital
Vanguard Group
Wellington Management Company
Arrowpoint Asset Management
Pivotal bioVenture Partners Investment Advisor

View all funds holding Zenas Biopharma